208 related articles for article (PubMed ID: 34153451)
1. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial.
Klingmann V; Linderskamp H; Meissner T; Mayatepek E; Moeltner A; Breitkreutz J; Bosse HM
J Pediatr; 2018 Oct; 201():202-207.e1. PubMed ID: 29960767
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial.
Klingmann V; Seitz A; Meissner T; Breitkreutz J; Moeltner A; Bosse HM
J Pediatr; 2015 Oct; 167(4):893-896.e2. PubMed ID: 26259675
[TBL] [Abstract][Full Text] [Related]
6. A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population.
Wargenau M; Reidemeister S; Klingmann I; Klingmann V
Ther Innov Regul Sci; 2022 Nov; 56(6):903-909. PubMed ID: 35471561
[TBL] [Abstract][Full Text] [Related]
7. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
[TBL] [Abstract][Full Text] [Related]
9. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
Klingmann V
AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
[TBL] [Abstract][Full Text] [Related]
11. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
[TBL] [Abstract][Full Text] [Related]
12. Evidence of acceptability of oral paediatric medicines: a review.
Mistry P; Batchelor H;
J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
[TBL] [Abstract][Full Text] [Related]
13. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.
Spomer N; Klingmann V; Stoltenberg I; Lerch C; Meissner T; Breitkreutz J
Arch Dis Child; 2012 Mar; 97(3):283-6. PubMed ID: 22253279
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of different oral formulations in infants and preschool children.
van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
[TBL] [Abstract][Full Text] [Related]
15. Methods of administering oral formulations and child acceptability.
van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
[TBL] [Abstract][Full Text] [Related]
16. Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products.
Wargenau M; Baase F; Eckardt K; Spitzhorn LS; Reidemeister S; Klingmann I; Klingmann V
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675176
[TBL] [Abstract][Full Text] [Related]
17. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
Thabet Y; Klingmann V; Breitkreutz J
J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
[TBL] [Abstract][Full Text] [Related]
18. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
Bélard S; Ramharter M; Kurth F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
[TBL] [Abstract][Full Text] [Related]
19. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
Comoglu T; Dilek Ozyilmaz E
Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
[TBL] [Abstract][Full Text] [Related]
20. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]